|British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus|
RC Fitzgerald, M di Pietro, K Ragunath, Y Ang, JY Kang, P Watson, ...
Gut 63 (1), 7-42, 2014
|Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial|
KN Phoa, FGI Van Vilsteren, BLAM Weusten, R Bisschops, EJ Schoon, ...
Jama 311 (12), 1209-1217, 2014
|Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase|
L Stojic, N Mojas, P Cejka, M di Pietro, S Ferrari, G Marra, J Jiricny
Genes & development 18 (11), 1331-1344, 2004
|Methylation‐induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1|
P Cejka, L Stojic, N Mojas, AM Russell, K Heinimann, E Cannavˇ, ...
The EMBO journal 22 (9), 2245-2254, 2003
|Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement|
B Weusten, R Bisschops, E Coron, M Dinis-Ribeiro, JM Dumonceau, ...
Endoscopy 49 (02), 191-198, 2017
|Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma|
CS Ross-Innes, J Becq, A Warren, RK Cheetham, H Northen, ...
Nature genetics 47 (9), 1038-1046, 2015
|Nuclear aggregates of polyamines are supramolecular structures that play a crucial role in genomic DNA protection and conformation|
L D'Agostino, M Di Pietro, A Di Luccia
The FEBS journal 272 (15), 3777-3787, 2005
|Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treatedá…|
RJ Haidry, MA Butt, JM Dunn, A Gupta, G Lipman, HL Smart, P Bhandari, ...
Gut 64 (8), 1192-1199, 2015
|DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus|
MA Alvi, X Liu, M O'Donovan, R Newton, L Wernisch, NB Shannon, ...
Clinical Cancer Research 19 (4), 878-888, 2013
|The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus|
M di Pietro, DF Boerwinkel, MK Shariff, X Liu, E Telakis, P Lao-Sirieix, ...
Gut 64 (1), 49-56, 2015
|Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus|
M di Pietro, P Lao-Sirieix, S Boyle, A Cassidy, D Castillo, A Saadi, ...
Proceedings of the National Academy of Sciences 109 (23), 9077-9082, 2012
|Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers|
M di Pietro, JS Bellver, M Menigatti, F Bannwart, A Schnider, A Russell, ...
Gastroenterology 129 (3), 1047-1059, 2005
|Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance|
YC Lim, M di Pietro, M O'Donovan, S Richardson, I Debiram, ...
Gastrointestinal endoscopy 80 (1), 78-87, 2014
|British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma|
M Banks, D Graham, M Jansen, T Gotoda, S Coda, M Di Pietro, N Uedo, ...
Gut 68 (9), 1545-1575, 2019
|Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia|
M di Pietro, RC Fitzgerald
Gut 67 (2), 392-393, 2018
|Screening for Barrett’s esophagus|
M Di Pietro, D Chan, RC Fitzgerald, KK Wang
Gastroenterology 148 (5), 912-923, 2015
|Endoscopic management of early adenocarcinoma and squamous cell carcinoma of the esophagus: screening, diagnosis, and therapy|
M di Pietro, MI Canto, RC Fitzgerald
Gastroenterology 154 (2), 421-436, 2018
|The human squamous oesophagus has widespread capacity for clonal expansion from cells at diverse stages of differentiation|
M Barbera, M di Pietro, E Walker, C Brierley, S MacRae, BD Simons, ...
Gut 64 (1), 11-19, 2015
|Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status|
EZ Mi, EZ Mi, M di Pietro, M O’Donovan, RH Hardwick, S Richardson, ...
Gastrointestinal endoscopy 87 (2), 408-418, 2018
|Barrett’s esophagus and cancer risk: how research advances can impact clinical practice|
M Di Pietro, D Alzoubaidi, RC Fitzgerald
Gut and liver 8 (4), 356, 2014